You are here

INVOKANA®: Type 2 diabetes clinical trial program

INVOKANA® has been studied in 15 completed and ongoing clinical trials with more than 20,000 patients.1 Read about the designs of these trials and more, including how INVOKANA® works and information about type 2 diabetes.

Reference: 1. Data on file. Janssen Pharmaceuticals, Inc., Titusville, NJ.

Learn about ACCESS & SUPPORT